In this study, the analysis of AML patient samples revealed that m6A RNA methyltransferases (METTL3, METTL4 and WTAP) and demethylases (FTO and ALKBH5) had significantly greater positive ratios in AML patients than in NCs (Figure 1A,B). This evidence concerns the gene ALKBH5 and acute myeloid leukemia.